Deterioration of axotomy-induced neurodegeneration by group IIA secretory phospholipase A2.
D000818:Animals; D000831:Animals, Newborn; D019771:Axotomy; D002219:Carbamates / Q000494:pharmacology; D016923:Cell Death; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005154:Facial Nerve / Q000473:pathology / Q000503:physiopathology*; D007212:Indolizines / Q000494:pharmacology; D009046:Motor Neurons / Q000502:physiology; D009410:Nerve Degeneration / Q000503:physiopathology*; D018696:Neuroprotective Agents / Q000494:pharmacology; D010741:Phospholipases A / Q000037:antagonists & inhibitors / Q000502:physiology*; D054467:Phospholipases A2; D051381:Rats; D017207:Rats, Sprague-Dawley